Skip to main content

INVESTOR AB

Location
STOCKHOLM, V7
Portfolio Value
Large $15,147,938,220
Diversification
Highly concentrated
Filing Date
Global Rank
#320 / 8,605 ▲ 307 · as of Mar 2026
Top Industry
Drug Manufacturers - General 67.2%
3Y Alpha vs SPY
+4.8%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+98.3%
SPY
+76.5%
Annualised alpha
+4.8%
Max drawdown
−21.7%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

10 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
67.2%
−32.5 pts
Top 5
100.0%
+0.0 pts
Top 10
100.0%
+0.0 pts
HHI
5,582
Jun 2023 → Mar 2026 · range 5,582 – 9,983
Highly concentrated−4,342

Portfolio Trend

25 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 67.3% $10,188,406,319
Financial Services 32.7% $4,956,084,143
Technology 0.0% $2,025,926
Communication Services 0.0% $1,168,408
Consumer Cyclical 0.0% $253,424

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
2 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
2 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
4 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
5 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
10 positions · $15,147,938,220 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History